Seeking Alpha

Nektar Therapeutics (NKTR): Q4 EPS of -$0.24 may not be comparable with consensus of -$0.16....

Nektar Therapeutics (NKTR): Q4 EPS of -$0.24 may not be comparable with consensus of -$0.16. Revenue of $45.3M (+16% Y/Y) beats by $3.8M. Shares +2.7% AH. (PR)

Check out Seeking Alpha’s new Earnings Center »

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs